MENU
+Compare
MYNDF
Stock ticker: OTC
AS OF
May 20 closing price
Price
$0.03
Change
+$0.02 (+200.00%)
Capitalization
1.4M

MYNDF MYND Life Sciences Inc. Forecast, Technical & Fundamental Analysis

MYND Life Sciences Inc is a  medical biotech drug research and development company... Show more

MYNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MYNDF with price predictions
Jul 24, 2025

MYNDF sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for MYNDF moved above the 200-day moving average on July 17, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Aroon Indicator entered an Uptrend today. In of 41 cases where MYNDF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (18.664). P/E Ratio (0.000) is within average values for comparable stocks, (59.851). MYNDF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.578). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (279.346).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MYNDF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MYNDF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
MYNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
105-2248 Elgin Avenue
Phone
+1 780 965-0122
Employees
10
Web
https://www.myndsciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EP4.960.04
+0.81%
Empire Petroleum Corp
CW478.73-0.94
-0.20%
Curtiss-Wright Corp
GBDC15.36-0.12
-0.78%
Golub Capital BDC
PACK3.89-0.05
-1.27%
Ranpak Holdings Corp
BTAI1.73-0.08
-4.42%
BioXcel Therapeutics Inc

MYNDF and Stocks

Correlation & Price change

A.I.dvisor tells us that MYNDF and NERV have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MYNDF and NERV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYNDF
1D Price
Change %
MYNDF100%
N/A
NERV - MYNDF
29%
Poorly correlated
+8.50%
ICCC - MYNDF
23%
Poorly correlated
-2.73%
CSBR - MYNDF
20%
Poorly correlated
-14.19%
AEON - MYNDF
7%
Poorly correlated
-3.24%
INKT - MYNDF
4%
Poorly correlated
-5.28%
More